Zoetis Inc. (NYSE:ZTS) Given Consensus Rating of “Buy” by Brokerages

Shares of Zoetis Inc. (NYSE:ZTS) have earned an average rating of “Buy” from the ten analysts that are covering the firm, MarketBeat.com reports. Nine research analysts have rated the stock with a buy recommendation and one has issued a strong buy recommendation on the company. The average 1 year price target among brokerages that have issued a report on the stock in the last year is $221.44.

ZTS has been the subject of a number of recent research reports. BTIG Research lifted their price target on shares of Zoetis from $220.00 to $225.00 and gave the stock a “buy” rating in a research note on Monday, August 12th. Stifel Nicolaus lifted their price objective on shares of Zoetis from $200.00 to $210.00 and gave the stock a “buy” rating in a research report on Wednesday, September 18th. Piper Sandler boosted their target price on shares of Zoetis from $195.00 to $210.00 and gave the stock an “overweight” rating in a research note on Wednesday, August 14th. Argus upgraded Zoetis to a “strong-buy” rating in a research note on Friday, August 9th. Finally, JPMorgan Chase & Co. upped their price objective on Zoetis from $225.00 to $230.00 and gave the stock an “overweight” rating in a research report on Friday, October 11th.

Zoetis Price Performance

Zoetis stock opened at $176.96 on Monday. The company’s 50 day moving average is $185.62 and its two-hundred day moving average is $180.72. The firm has a market cap of $79.84 billion, a PE ratio of 33.26, a price-to-earnings-growth ratio of 2.71 and a beta of 0.90. The company has a quick ratio of 2.27, a current ratio of 3.69 and a debt-to-equity ratio of 1.26. Zoetis has a 52-week low of $144.80 and a 52-week high of $201.92.

Zoetis (NYSE:ZTS) last released its earnings results on Monday, November 4th. The company reported $1.58 EPS for the quarter, topping the consensus estimate of $1.46 by $0.12. The firm had revenue of $2.40 billion during the quarter, compared to analysts’ expectations of $2.29 billion. Zoetis had a return on equity of 51.98% and a net margin of 26.55%. Zoetis’s revenue for the quarter was up 11.6% on a year-over-year basis. During the same period in the previous year, the firm posted $1.36 EPS. On average, research analysts expect that Zoetis will post 5.9 EPS for the current fiscal year.

Zoetis Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Tuesday, December 3rd. Investors of record on Thursday, October 31st will be paid a dividend of $0.432 per share. The ex-dividend date is Thursday, October 31st. This represents a $1.73 dividend on an annualized basis and a yield of 0.98%. Zoetis’s dividend payout ratio is presently 32.52%.

Hedge Funds Weigh In On Zoetis

Institutional investors have recently modified their holdings of the business. Darwin Wealth Management LLC purchased a new position in Zoetis during the 3rd quarter worth $31,000. First Personal Financial Services purchased a new stake in shares of Zoetis in the third quarter valued at about $33,000. Capital Performance Advisors LLP acquired a new stake in shares of Zoetis during the third quarter worth about $33,000. Dunhill Financial LLC grew its holdings in shares of Zoetis by 80.6% during the third quarter. Dunhill Financial LLC now owns 168 shares of the company’s stock worth $33,000 after buying an additional 75 shares during the last quarter. Finally, Quarry LP increased its position in Zoetis by 273.2% in the 2nd quarter. Quarry LP now owns 209 shares of the company’s stock valued at $36,000 after acquiring an additional 153 shares during the period. 92.80% of the stock is owned by institutional investors and hedge funds.

Zoetis Company Profile

Zoetis Inc engages in the discovery, development, manufacture, and commercialization of animal health medicines, vaccines, and diagnostic products and services in the United States and internationally. The company commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep and others; and companion animals comprising dogs, cats, and horses.